Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86


Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model.

Niu S, Zhang LK, Zhang L, Zhuang S, Zhan X, Chen WY, Du S, Yin L, You R, Li CH, Guan YQ.

Theranostics. 2017 Jan 1;7(2):344-356. doi: 10.7150/thno.16562.


Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study.

Schroeder LA, Rufra O, Sauvageot N, Fays F, Pieri V, Diederich NJ.

Sleep. 2016 Dec 1;39(12):2133-2139. doi: 10.5665/sleep.6312.


Obstructive Sleep Apnea and Cognition in Parkinson's disease.

Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S.

Sleep Med. 2016 May;21:28-34. doi: 10.1016/j.sleep.2016.01.001.


Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment.

Kasemsap N, Onsanit S, Chiewthanakul P, Kongbunkiat K, Tanking C, Vorasoot N, Sawanyawisuth K, Tiamkao S.

Neuropsychiatr Dis Treat. 2016 May 11;12:1185-9. doi: 10.2147/NDT.S98597.


Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials.

Ferreira JJ, Mestre T, Guedes LC, Coelho M, Rosa MM, Santos AT, Barra M, Sampaio C, Rascol O.

Front Neurol. 2016 Mar 8;7:27. doi: 10.3389/fneur.2016.00027.


Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging.

Lin WC, Chen PC, Huang YC, Tsai NW, Chen HL, Wang HC, Lin TK, Chou KH, Chen MH, Chen YW, Lu CH.

Medicine (Baltimore). 2016 Feb;95(5):e2206. doi: 10.1097/MD.0000000000002206.


Automatic Sleep Stage Scoring Using Time-Frequency Analysis and Stacked Sparse Autoencoders.

Tsinalis O, Matthews PM, Guo Y.

Ann Biomed Eng. 2016 May;44(5):1587-97. doi: 10.1007/s10439-015-1444-y.


End of OSLER Test Sessions in Parkinson's Disease do not Correspond to True Sleep Onset: Results from an Exploratory Study.

Neutel D, Peralta R, Pires J, Bentes C, Ferreira JJ.

Front Neurol. 2015 Sep 24;6:200. doi: 10.3389/fneur.2015.00200.


Serial macro-architectural alterations with levodopa in Parkinson's disease: Polysomnography (PSG)-based analysis.

Joy SP, Sinha S, Pal PK, Panda S, Philip M, Taly AB.

Ann Indian Acad Neurol. 2015 Jul-Sep;18(3):309-13. doi: 10.4103/0972-2327.160102.


Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.

Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A, Calopa M, Casquero P, de Fàbregues O, Jaumà S, Puente V, Salamero M, José Martí M, Santamaría J, Tolosa E.

PLoS One. 2015 Jul 15;10(7):e0132368. doi: 10.1371/journal.pone.0132368.


Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.

Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K; PPMI Sleep Working group on behalf of the PPMI Investigators..

Mov Disord. 2015 Sep;30(10):1371-81. doi: 10.1002/mds.26248.


Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.

Arnulf I, Neutel D, Herlin B, Golmard JL, Leu-Semenescu S, Cochen de Cock V, Vidailhet M.

Sleep. 2015 Oct 1;38(10):1529-35. doi: 10.5665/sleep.5040.


Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Salawu F, Olokoba A.

Oman Med J. 2015 Jan;30(1):3-10. doi: 10.5001/omj.2015.02. Review.


Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis.

Zhang G, Xiong N, Zhang Z, Liu L, Huang J, Yang J, Wu J, Lin Z, Wang T.

PLoS One. 2015 Mar 10;10(3):e0118498. doi: 10.1371/journal.pone.0118498. Review.


Psychiatric aspects of Parkinson's disease.

Grover S, Somaiya M, Kumar S, Avasthi A.

J Neurosci Rural Pract. 2015 Jan;6(1):65-76. doi: 10.4103/0976-3147.143197. Review.


Daytime sleepiness in Parkinson's disease: a reappraisal.

Cochen De Cock V, Bayard S, Jaussent I, Charif M, Grini M, Langenier MC, Yu H, Lopez R, Geny C, Carlander B, Dauvilliers Y.

PLoS One. 2014 Sep 8;9(9):e107278. doi: 10.1371/journal.pone.0107278.


Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.

Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D.

Neurology. 2014 Aug 26;83(9):826-33. doi: 10.1212/WNL.0000000000000729.


Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.

Belaid H, Adrien J, Laffrat E, Tandé D, Karachi C, Grabli D, Arnulf I, Clark SD, Drouot X, Hirsch EC, François C.

J Neurosci. 2014 Jul 2;34(27):9124-33. doi: 10.1523/JNEUROSCI.0181-14.2014.

Items per page

Supplemental Content

Support Center